Immunic, INC. (IMUX) — SC 13G Filings

All SC 13G filings from Immunic, INC.. Browse 5 Passive Stake Filing reports with AI-powered summaries and risk analysis.

SC 13G Filings (5)

SC 13G Filing — Nov 12, 2024
Janus Henderson Group Takes 7.4% Stake in Immunic, Inc. — Jan 18, 2024
Janus Henderson Group plc, a major investment firm, reported on January 18, 2024, that it now beneficially owns 7.4% of Immunic, Inc.'s Common Stock. This signi
Biotechnology Value Fund L.P. Takes New Passive Stake in Immunic, Inc. — Jan 18, 2024
Biotechnology Value Fund L.P. has reported a new passive stake in Immunic, Inc. (IMUX) as of January 8, 2024. This filing, an SC 13G, indicates that Biotechnolo
Avidity Partners Discloses 9.9% Stake in Immunic (IMUX) — Jan 16, 2024
Avidity Partners Management LP, an investment firm based in Dallas, TX, has disclosed a significant stake in Immunic, Inc. (IMUX), a pharmaceutical company. As
Soleus Capital Discloses New Passive Stake in IMMUNIC (IMUX) — Jan 10, 2024
Soleus Private Equity Fund III, L.P. and its affiliates, including Soleus Capital Group, LLC and Guy Levy, have reported a new passive ownership stake in IMMUNI

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX